[1]
Kiyani, M. et al. 2026. Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. Journal of Hematology. 15, 5 (Jan. 2026), 219–224. DOI:https://doi.org/10.14740/jh2233.